Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi (Q35277854)

7 August 2017

1 reference

title

Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi (English)

1 reference

7 August 2017

Andrea Bartoli

6

0 references

Silvia Moretti

Silvia Moretti

5

0 references

Antonella De Luca

Antonella De Luca

3

0 references

Teresa Zelante

Teresa Zelante

2

0 references

Franco Aversa

Franco Aversa

7

0 references

Paolo Puccetti

Paolo Puccetti

8

0 references

Luigina Romani

Luigina Romani

1

0 references

Rossana G Iannitti

4

Rossana G Iannitti

1 reference

PubMed ID

25256754

7 August 2017

language of work or name

English

0 references

publication date

20 October 2014

1 reference

European Journal of Immunology

7 August 2017

1 reference

7 August 2017

44

1 reference

7 August 2017

3192-3200

1 reference

7 August 2017

11

1 reference

The emerging world of the fungal microbiome

7 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The mycobiota: interactions between commensal fungi and the host immune system.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The bacteriome-mycobiome interaction and antifungal host defense

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Immunity to fungal infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Characterization of the oral fungal microbiome (mycobiome) in healthy individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Colonization by Pneumocystis jirovecii and its role in disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The human mycobiome in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Topographic diversity of fungal and bacterial communities in human skin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Role of antibiotics and fungal microbiota in driving pulmonary allergic responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Fungi and inflammatory bowel diseases: Alterations of composition and diversity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Medically important bacterial-fungal interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Review article: fungal microbiota and digestive diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Vulvovaginal candidosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Primary immunodeficiencies underlying fungal infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The damage-response framework of microbial pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Surface hydrophobin prevents immune recognition of airborne fungal spores

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Oxylipins as developmental and host-fungal communication signals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Interactions between the microbiota and the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Sensing of mammalian IL-17A regulates fungal adaptation and virulence.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Inflammation and gastrointestinal Candida colonization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Candida albicans and cancer: Can this yeast induce cancer development or progression?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Sensitization to Malassezia in children with atopic dermatitis combined with food allergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The Malassezia genus in skin and systemic diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Endogenous kynurenines as targets for drug discovery and development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The human indoleamine 2,3-dioxygenase gene and related human genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Indoleamine 2,3-dioxygenase: from catalyst to signaling function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Adaptive immunity to fungi

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Immune reconstitution syndrome associated with opportunistic mycoses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Indoleamine 2,3-dioxygenases with very low catalytic activity are well conserved across kingdoms: IDOs of Basidiomycota.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The aryl hydrocarbon receptor: multitasking in the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The search for endogenous activators of the aryl hydrocarbon receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Activation of the Ah receptor by tryptophan and tryptophan metabolites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Functions of the aryl hydrocarbon receptor in the skin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit Toll-like receptor-induced maturation in monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Microbial metabolomics: innovation, application, insight

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Drug research: a comparison of ongoing research and perceived research priorities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The bacterial signalling molecule indole attenuates the virulence of the fungal pathogen Candida albicans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

IL-22 in antifungal immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Chronic mucocutaneous candidiasis, from bench to bedside

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Influences of Dietary and Environmental Stress on Microbial Populations in the Murine Gastrointestinal Tract

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Gene expression of commensal Lactobacillus johnsonii strain NCC533 during in vitro growth and in the murine gut.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Resource partitioning in relation to cohabitation of Lactobacillus species in the mouse forestomach

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

The role of microbiota and probiotics in stress-induced gastro-intestinal damage.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

IL-22 defines a novel immune pathway of antifungal resistance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344406

7 January 2021

Identifiers

DOI

10.1002/EJI.201344406

1 reference

7 August 2017

1 reference

PubMed ID

25256754